Clinical Benefits of a Metabolic Approach with Trimetazidine in Revascularized Patients with Angina
- 25 July 2006
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (5) , 8-13
- https://doi.org/10.1016/j.amjcard.2006.07.003
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable AnginaEuropean Heart Journal, 2005
- The initial management of stable angina in Europe, from the Euro Heart SurveyEuropean Heart Journal, 2005
- Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registryHeart, 2004
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Étude pacifique : postangioplastie coronaire en France et intervention thérapeutiqueAnnales de Cardiologie et d'Angéiologie, 2004
- Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trialThe Lancet, 2004
- The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery diseaseJournal of the American College of Cardiology, 2004
- Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapyJournal of the American College of Cardiology, 2003
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)The Lancet, 2003
- Outcome of Elderly Patients With Chronic Symptomatic Coronary Artery Disease With an Invasive vs Optimized Medical Treatment StrategyJAMA, 2003